Association of Sp1 and survivin in epithelial ovarian cancer: Sp1 inhibitor and cisplatin, a novel combination for inhibiting epithelial ovarian cancer cell proliferation Article

Industry Collaboration International Collaboration

cited authors

  • Sankpal, Umesh T.; Ingersoll, Susan B.; Ahmad, Sarfraz; Holloway, Robert W.; Bhat, Vadiraja B.; Simecka, Jerry W.; Daniel, Liz; Kariali, Ekamber; Vishwanatha, Jamboor K.; Basha, Riyaz

authors

Publication Date

  • October 1, 2016

webpage

published in

category

keywords

  • Cisplatin
  • Epithelial ovarian cancer
  • Sp1
  • Survivin
  • Tolfenamic acid

start page

  • 14259

end page

  • 14269

volume

  • 37

issue

  • 10